Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ischemia: early-phase trial registry
5 of 12 indexed Ischemia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 5 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Ischemia: 12 US clinical trials tracked, 5 recruiting.
Ischemia is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is UConn Health, running 2 of these trials.
Enrollment posture brief
Registry condition ischemia
OPEN 5 | RECR 42% | LATE 0 | EARLY 1 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adiposity (42% recruiting · 12 trials)
Ischemia lists 5 open slots (42% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ischemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ischemia is recruiting below its size-band peers.
5 of 12 indexed trials (41.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ischemia research.
UConn Health accounts for 2 of 12 trials (16.7%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Ischemia enrolment sits around 300 participants.
Median target enrolment is 300 among the 12 trials that report a genuine target (sentinel values excluded). 2 of those (16.7%) plan for fewer than 100 participants.
-
Ischemia splits between interventional and observational designs.
6 interventional and 6 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Evaluation of Patients With Non-obstructive Coronary Arteries
Stanford University
NCT00823563
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
NCT06271577
Circulating Markers for Ischemic Heart Disease
UConn Health
NCT00762333
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
UConn Health
NCT04321512
mHealth-CArdiac REhabilitation for INOCA
NYU Langone Health
NCT06829160
The Chocolate Touch Study
TriReme Medical
NCT02924857
Goal-directed CPR Using Cerebral Oximetry
NYU Langone Health
NCT04924985
pRESET for Occlusive Stroke Treatment
phenox
NCT03994822
WARRIOR Ancillary Study for CCTA Analysis
Cedars-Sinai Medical Center
NCT05035056
Evaluation of Treated and Untreated Stroke
National Institutes of Health Clinical Center (CC)
NCT00001840
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Indiana University
NCT02685098
Biomagnetic Characterization of Gastric Dysrhythmias:Study 2
Vanderbilt University Medical Center
NCT00178984
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ischemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ischemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ischemia page
12 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Ischemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- UConn Health sponsors the most Ischemia trials on record, review their full trial history before evaluating a specific study. See UConn Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemia condition card totals 12 registered trials; most-linked intervention Allogeneic bone marrow derived mesenchymal stem cells; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.